EA201391314A1 - Новое фенилпиридиновое производное и содержащее его лекарственное средство - Google Patents
Новое фенилпиридиновое производное и содержащее его лекарственное средствоInfo
- Publication number
- EA201391314A1 EA201391314A1 EA201391314A EA201391314A EA201391314A1 EA 201391314 A1 EA201391314 A1 EA 201391314A1 EA 201391314 A EA201391314 A EA 201391314A EA 201391314 A EA201391314 A EA 201391314A EA 201391314 A1 EA201391314 A1 EA 201391314A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compound
- ring
- alkyl group
- present
- phenilpyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение обеспечивает соединение, которое обладает как антагонизмом в отношении рецептора ангиотензина II, так и эффектом активации PPARγ и которое является полезным в качестве профилактического и/или терапевтического средства для лечения повышенного давления, сердечного заболевания, артериосклероза, диабета 2 типа, диабетических осложнений, метаболического синдрома и т.п.; и композицию лекарственного средства, содержащую такое соединение. Настоящее изобретение относится к соединению, представленному общей формулой (I) (в формуле кольцо А представляет собой пиридиновое кольцо; кольцо В представляет собой тетразольное кольцо или оксадиазол-5(4Н)-оновое кольцо; X представляет собой C-Rили атом азота; Rпредставляет собой Cалкильную группу, Rпредставляет собой Cалкильную группу или Сциклоалкильную группу; и R, Rи R, каждый независимо, представляют собой атом водорода, атом галогена, Cалкильную группу, галоген Cалкильную группу или необязательно замещенную Cалкоксигруппу), или соли такого соединения, или их сольвату и к композиции лекарственного средства, содержащей такое соединение.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011055691 | 2011-03-14 | ||
PCT/JP2012/001709 WO2012124311A1 (ja) | 2011-03-14 | 2012-03-13 | 新規なフェニルピリジン誘導体及びこれを含有する医薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201391314A1 true EA201391314A1 (ru) | 2014-02-28 |
EA026694B1 EA026694B1 (ru) | 2017-05-31 |
Family
ID=46830402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391314A EA026694B1 (ru) | 2011-03-14 | 2012-03-13 | Фенилпиридиновое производное и содержащее его лекарственное средство |
Country Status (22)
Country | Link |
---|---|
US (1) | US9315493B2 (ru) |
EP (1) | EP2687523B1 (ru) |
JP (1) | JP5583841B2 (ru) |
KR (1) | KR101559307B1 (ru) |
CN (1) | CN103459380B (ru) |
AU (1) | AU2012227763B2 (ru) |
BR (1) | BR112013023038B1 (ru) |
CA (1) | CA2830043C (ru) |
CY (1) | CY1117348T1 (ru) |
DK (1) | DK2687523T3 (ru) |
EA (1) | EA026694B1 (ru) |
ES (1) | ES2562994T3 (ru) |
HK (1) | HK1189232A1 (ru) |
HU (1) | HUE028252T2 (ru) |
MX (1) | MX349697B (ru) |
PL (1) | PL2687523T3 (ru) |
PT (1) | PT2687523E (ru) |
RS (1) | RS54666B1 (ru) |
SG (1) | SG193477A1 (ru) |
TW (1) | TWI525088B (ru) |
WO (1) | WO2012124311A1 (ru) |
ZA (1) | ZA201307333B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690955B (zh) * | 2013-12-27 | 2016-04-20 | 福州乾正药业有限公司 | 含有替格瑞洛的药物组合物及其制备方法和药物应用 |
US20210077491A1 (en) * | 2017-12-14 | 2021-03-18 | Kowa Company, Ltd. | Pharmaceutical composition |
CN115138481B (zh) * | 2022-07-06 | 2024-01-26 | 中南大学 | 一种将方铅矿、闪锌矿中的至少一种矿物与辉钼矿浮选分离的药剂和方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5331165A (en) * | 1976-09-03 | 1978-03-24 | Iseki Kaihatsu Koki | Continuous specific gravity meter |
JPS5779456A (en) * | 1980-11-06 | 1982-05-18 | Fujitsu Ltd | Voltage readout system by electron beam |
JPS6211845A (ja) * | 1985-07-10 | 1987-01-20 | Sharp Corp | 複写装置 |
US5472967A (en) | 1991-02-20 | 1995-12-05 | Synthelabo | 4-pyrimidinone derivatives their preparation and their application in therapy |
CN1079223A (zh) * | 1991-05-16 | 1993-12-08 | 格拉克索公司 | 苯并呋喃衍生物 |
JPH06211845A (ja) | 1991-05-16 | 1994-08-02 | Glaxo Group Ltd | ベンゾフラン誘導体 |
IL102183A (en) | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
US5212177A (en) * | 1991-12-16 | 1993-05-18 | E. R. Squibb & Sons, Inc. | Indole and benzimidazole-substituted dihydropyrimidine derivatives |
JPH07179456A (ja) | 1993-12-21 | 1995-07-18 | Nkk Corp | アルキルベンゾフラン誘導体及びアンジオテンシンii拮抗剤 |
IT1273790B (it) | 1994-02-18 | 1997-07-10 | Guidotti & C Spa Labor | Derivati eterociclici diazotati aventi attivita' aii antagonista |
US20100056526A1 (en) * | 2006-11-24 | 2010-03-04 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound and use thereof |
ZA200903867B (en) * | 2006-11-24 | 2010-08-25 | Takeda Pharmaceutical | Heteromonocyclic compound and use thereof |
CA2671943A1 (en) | 2006-12-21 | 2008-07-17 | Pfizer Products Inc. | Compounds having both angiotensin ii receptor antagonism and ppary activating activities |
KR101126383B1 (ko) | 2007-02-07 | 2012-04-12 | 교와 핫꼬 기린 가부시키가이샤 | 3환계 화합물 |
WO2008096820A1 (ja) | 2007-02-07 | 2008-08-14 | Kyowa Hakko Kirin Co., Ltd. | ビフェニル誘導体 |
EP2151440A4 (en) | 2007-05-21 | 2010-10-20 | Takeda Pharmaceutical | Heterocyclic compound and its use |
WO2010095462A1 (ja) | 2009-02-23 | 2010-08-26 | 興和株式会社 | 新規な3-(5-アルコキシピリミジン-2-イル)ピリミジン-4(3h)-オン構造を有する化合物及びこれを含有する医薬 |
JPWO2010119700A1 (ja) | 2009-04-17 | 2012-10-22 | 興和株式会社 | 新規な3−ヘテロアリールピリミジン−4−(3h)−オン構造を有する化合物及びこれを含有する医薬 |
PT2484675E (pt) | 2009-09-29 | 2015-01-13 | Kowa Co | Novo derivado de fenilpiridina e agente medicinal que compreende o mesmo |
-
2012
- 2012-03-13 KR KR1020137026800A patent/KR101559307B1/ko active IP Right Grant
- 2012-03-13 WO PCT/JP2012/001709 patent/WO2012124311A1/ja active Application Filing
- 2012-03-13 PL PL12757676T patent/PL2687523T3/pl unknown
- 2012-03-13 TW TW101108422A patent/TWI525088B/zh not_active IP Right Cessation
- 2012-03-13 EA EA201391314A patent/EA026694B1/ru not_active IP Right Cessation
- 2012-03-13 CA CA2830043A patent/CA2830043C/en not_active Expired - Fee Related
- 2012-03-13 US US14/005,046 patent/US9315493B2/en not_active Expired - Fee Related
- 2012-03-13 EP EP12757676.7A patent/EP2687523B1/en active Active
- 2012-03-13 RS RS20160147A patent/RS54666B1/en unknown
- 2012-03-13 JP JP2013504561A patent/JP5583841B2/ja not_active Expired - Fee Related
- 2012-03-13 SG SG2013069398A patent/SG193477A1/en unknown
- 2012-03-13 DK DK12757676.7T patent/DK2687523T3/en active
- 2012-03-13 ES ES12757676.7T patent/ES2562994T3/es active Active
- 2012-03-13 HU HUE12757676A patent/HUE028252T2/en unknown
- 2012-03-13 MX MX2013010553A patent/MX349697B/es active IP Right Grant
- 2012-03-13 PT PT127576767T patent/PT2687523E/pt unknown
- 2012-03-13 CN CN201280006094.2A patent/CN103459380B/zh not_active Expired - Fee Related
- 2012-03-13 BR BR112013023038A patent/BR112013023038B1/pt not_active IP Right Cessation
- 2012-03-13 AU AU2012227763A patent/AU2012227763B2/en not_active Ceased
-
2013
- 2013-10-02 ZA ZA2013/07333A patent/ZA201307333B/en unknown
-
2014
- 2014-03-10 HK HK14102384.4A patent/HK1189232A1/zh not_active IP Right Cessation
-
2016
- 2016-03-31 CY CY20161100263T patent/CY1117348T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
EA201590453A1 (ru) | Конденсированные бициклические производные сульфамоила и их применение в качестве лекарственных препаратов для лечения гепатита b | |
EA201200318A1 (ru) | Гетероциклические оксимы | |
EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
EA201590450A1 (ru) | Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b | |
EA201391029A1 (ru) | Производные оксазина и их применение при лечении неврологических нарушений | |
EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
NZ598085A (en) | Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid | |
BR112014032734A2 (pt) | derivados de pirrolidina e seu uso como moduladores da série de reação de complemento | |
EA201270492A1 (ru) | Соединения для лечения дислипидемии и связанных с ней заболеваний | |
EA201491671A1 (ru) | Гетероциклильные соединения | |
EA200901423A1 (ru) | Бензимидазолы и содержащие их фармацевтические композиции | |
EA201270560A1 (ru) | Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета | |
EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
EA201391525A1 (ru) | Гликозидные производные и их применение для лечения диабета | |
RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
WO2013028818A8 (en) | Pyrimido- pyridazinone compounds and use thereof | |
WO2012101065A3 (en) | Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors | |
EA201490630A1 (ru) | 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы | |
RU2015116540A (ru) | Замещенные соединения спиропиперидинила, применяемые в качестве агонистов gpr120 | |
GEP20156319B (en) | Asymmetric ureas and medical uses thereof | |
RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
RU2015150120A (ru) | Соединение дикарбоновой кислоты | |
EA201391026A1 (ru) | Кристаллическое производное оксазина и его применение в качестве ингибитора bace | |
RU2014132046A (ru) | Макроциклические амиды в качестве ингибиторов протеазы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |